hormone replacement therapydrug that combines esterified estrogenswith methyltestosteronein one pill.
Estratest is used to treat menopausal women who suffer from hot flashes but do not get relief from estrogen-only therapy
Estratest was first marketed in the United States in 1965 by Reid-Provident Laboratories, which as 100% of Reid-Rowell, Inc. stock was acquired by the Belgian pharmaceutical company Solvay in 1986. There has been some controversy surrounding the drug in recent years as to its status with the FDA.
Solvay is currently sponsoring a clinical trial of Estratest in the United States to determine whether the product is superior to treatment with esterified estrogens tablets
Estratest is sold in tablet form, with either 1.25 mg estrogens/2.5 mg methyltestosterone or 0.625 mg estrogens/1.25 mg methyltestosterone available.
Estratest is supplied by Solvay.
* August 2003 press release from the Prescription Access Litigation project [http://www.communitycatalyst.org/index.php?doc_id=136] .
* [http://www.solvaypharmaceuticals-us.com/products/estratestproductinformation/0,,12415-2-0,00.htm The product's web site]
* [http://www.clinicaltrials.gov/ct/show/NCT00141557 The clinical trial site]
Wikimedia Foundation. 2010.